Literature DB >> 29192815

New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Russell P Bowler, Chris H Wendt, Michael B Fessler, Matthew W Foster, Rachel S Kelly, Jessica Lasky-Su, Angela J Rogers, Kathleen A Stringer, Brent W Winston.   

Abstract

This document presents the proceedings from the workshop entitled, "New Strategies and Challenges in Lung Proteomics and Metabolomics" held February 4th-5th, 2016, in Denver, Colorado. It was sponsored by the National Heart Lung Blood Institute, the American Thoracic Society, the Colorado Biological Mass Spectrometry Society, and National Jewish Health. The goal of this workshop was to convene, for the first time, relevant experts in lung proteomics and metabolomics to discuss and overcome specific challenges in these fields that are unique to the lung. The main objectives of this workshop were to identify, review, and/or understand: (1) emerging technologies in metabolomics and proteomics as applied to the study of the lung; (2) the unique composition and challenges of lung-specific biological specimens for metabolomic and proteomic analysis; (3) the diverse informatics approaches and databases unique to metabolomics and proteomics, with special emphasis on the lung; (4) integrative platforms across genetic and genomic databases that can be applied to lung-related metabolomic and proteomic studies; and (5) the clinical applications of proteomics and metabolomics. The major findings and conclusions of this workshop are summarized at the end of the report, and outline the progress and challenges that face these rapidly advancing fields.

Entities:  

Keywords:  biomarkers; lung diseases; mass spectrometry; nuclear magnetic resonance; systems biology

Mesh:

Substances:

Year:  2017        PMID: 29192815      PMCID: PMC5946579          DOI: 10.1513/AnnalsATS.201710-770WS

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  146 in total

Review 1.  Can we discover novel pathways using metabolomic analysis?

Authors:  Wolfram Weckwerth; Oliver Fiehn
Journal:  Curr Opin Biotechnol       Date:  2002-04       Impact factor: 9.740

2.  A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.

Authors:  Michael B Fessler; Kenneth C Malcolm; Mark William Duncan; G Scott Worthen
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

3.  Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury.

Authors:  Russell P Bowler; Beth Duda; Edward D Chan; Jan J Enghild; Lorraine B Ware; Michael A Matthay; Mark W Duncan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-01-23       Impact factor: 5.464

4.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics.

Authors:  Hongbin Liu; Rovshan G Sadygov; John R Yates
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

5.  Exhaled breath condensate: methodological recommendations and unresolved questions.

Authors:  I Horváth; J Hunt; P J Barnes; K Alving; A Antczak; E Baraldi; G Becher; W J C van Beurden; M Corradi; R Dekhuijzen; R A Dweik; T Dwyer; R Effros; S Erzurum; B Gaston; C Gessner; A Greening; L P Ho; J Hohlfeld; Q Jöbsis; D Laskowski; S Loukides; D Marlin; P Montuschi; A C Olin; A E Redington; P Reinhold; E L J van Rensen; I Rubinstein; P Silkoff; K Toren; G Vass; C Vogelberg; H Wirtz
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

6.  Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage.

Authors:  Carlos de Torre; Sai-Xia Ying; Peter J Munson; G Umberto Meduri; Anthony F Suffredini
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

7.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

8.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

9.  Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury.

Authors:  Lynn M Schnapp; Samuel Donohoe; Jinzhi Chen; Donald A Sunde; Patricia M Kelly; John Ruzinski; Thomas Martin; David R Goodlett
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

10.  Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.

Authors:  Dietrich Merkel; Wolfgang Rist; Peter Seither; Andreas Weith; Martin C Lenter
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

View more
  19 in total

1.  Response.

Authors:  Rachel S Kelly; Jessica Lasky-Su
Journal:  Chest       Date:  2018-05       Impact factor: 9.410

Review 2.  Lung microbial-host interface through the lens of multi-omics.

Authors:  Shivani Singh; Jake G Natalini; Leopoldo N Segal
Journal:  Mucosal Immunol       Date:  2022-07-06       Impact factor: 8.701

3.  Metabolomics of bronchoalveolar lavage in children with persistent wheezing.

Authors:  Lingfang Liang; Minfei Hu; Yuanling Chen; Lingke Liu; Lei Wu; Chengcheng Hang; Xiaofei Luo; Xuefeng Xu
Journal:  Respir Res       Date:  2022-06-19

4.  Metabolomics in the prevention and management of asthma.

Authors:  Zhaozhong Zhu; Carlos A Camargo; Kohei Hasegawa
Journal:  Expert Rev Respir Med       Date:  2019-10-09       Impact factor: 3.772

5.  A shift from glycolytic and fatty acid derivatives toward one-carbon metabolites in the developing lung during transitions of the early postnatal period.

Authors:  Daniel D Lee; Sang Jun Park; Kirsten L Zborek; Margaret A Schwarz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-27       Impact factor: 5.464

Review 6.  Protein Biomarkers for COPD Outcomes.

Authors:  Karina A Serban; Katherine A Pratte; Russell P Bowler
Journal:  Chest       Date:  2021-01-09       Impact factor: 10.262

Review 7.  Systems Biology ARDS Research with a Focus on Metabolomics.

Authors:  Sayed M Metwaly; Brent W Winston
Journal:  Metabolites       Date:  2020-05-19

Review 8.  HSP90 Inhibition and Modulation of the Proteome: Therapeutical Implications for Idiopathic Pulmonary Fibrosis (IPF).

Authors:  Ruben Manuel Luciano Colunga Biancatelli; Pavel Solopov; Betsy Gregory; John D Catravas
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

9.  Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.

Authors:  Bartolome R Celli; Julie A Anderson; Robert Brook; Peter Calverley; Nicholas J Cowans; Courtney Crim; Ian Dixon; Victor Kim; Fernando J Martinez; Andrea Morris; David E Newby; Julie Yates; Joergen Vestbo
Journal:  BMJ Open Respir Res       Date:  2019-05-04

10.  Proteome signature difference between respiratory viruses is associated with severity of bronchiolitis.

Authors:  Tadao Ooka; Yoshihiko Raita; Debby Ngo; Jonathan M Mansbach; Zhaozhong Zhu; Carlos A Camargo; Kohei Hasegawa
Journal:  Pediatr Allergy Immunol       Date:  2021-08-04       Impact factor: 6.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.